Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-08 @ 2:07 AM
Study NCT ID:
NCT01302795
Status:
COMPLETED
Last Update Posted:
2016-09-27
First Post:
2011-02-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab for Pyoderma Gangrenosum
Sponsor:
University of Zurich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-17
First Submit QC Date:
None
Study First Post Date:
2011-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-26
Last Update Post Date:
2016-09-27
Last Update Post Date Type:
ESTIMATED